Header Logo

ANISHA PATEL

TitleAssistant Professor
InstitutionMD Anderson
DepartmentDermatology
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Muhaj FF, Tran J, Dai J, Pacha O, Patel AB. A retrospective case series of eight patients with epidermal growth factor receptor inhibitor-induced cutaneous toxicities managed with dupilumab. JAAD Case Rep. 2024 Dec; 54:17-22. PMID: 39583056; PMCID: PMC11584517.
      Citations:    
    2. Iriarte C, Yeh JE, Alloo A, Boull C, Carlberg VM, Coughlin CC, Lara-Corrales I, Levy R, Nguyen CV, Oza VS, Patel AB, Rotemberg V, Shah SD, Zheng L, Miller CH, Hlobik M, Daigneault J, Choi JN, Huang JT, Vivar KL. Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature. Support Care Cancer. 2024 Aug 23; 32(9):610. PMID: 39174797.
      Citations:    Fields:    Translation:Humans
    3. Keam S, Turner N, Kugeratski FG, Rico R, Colunga-Minutti J, Poojary R, Alekseev S, Patel AB, Li YJ, Sheshadri A, Loghin ME, Woodman K, Aaroe AE, Hamidi S, Iyer PC, Palaskas NL, Wang Y, Nurieva R. Toxicity in the era of immune checkpoint inhibitor therapy. Front Immunol. 2024; 15:1447021. PMID: 39247203; PMCID: PMC11377343.
      Citations:    Fields:    Translation:HumansAnimals
    4. Tripathy S, Warbasse E, Ronen S, Al-Rohil R, Cohen GF, Chen WS, Patel AB. Clinicopathologic correlation of dermatologic diseases in patients with darker pigmentation. Am J Clin Pathol. 2024 Aug 01; 162(2):115-140. PMID: 38513285.
      Citations:    Fields:    Translation:Humans
    5. Chen ST, Semenov YR, Alloo A, Bach DQ, Betof Warner A, Bougrine A, Burton L, Cappelli LC, Castells M, Cohen J, Dewan AK, Fadden R, Guggina L, Hegde A, Huang V, Johnson DB, Kaffenberger B, Kroshinsky D, Kwatra S, Kwong B, Lacouture ME, Larocca C, Leventhal J, Markova A, McDunn J, Mooradian MJ, Naidoo J, Choi J, Nambudiri V, Nelson CA, Patel AB, Pimkina J, Rine J, Rubin KM, Sauder M, Shaigany S, Shariff A, Sullivan RJ, Zubiri L, Reynolds KL, LeBoeuf NR. Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy. J Immunother Cancer. 2024 Apr 10; 12(4). PMID: 38599660; PMCID: PMC11015215.
      Citations: 2     Fields:    Translation:Humans
    6. Fayle SE, Palaskas NL, Siddiqui BA, McQuade JL, Lin JS, Subudhi SK, Patel AB, Jenq RR, Shah AY, Spelman AR, Sun M, Marble BH, Wang Y, Fayle SE, Palaskas NL, Siddiqui BA, McQuade JL, Lin JS, Subudhi SK, Patel AB, Jenq RR, Shah AY, Spelman AR, Sun M, Marble BH, Wang Y. Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events. J Natl Compr Canc Netw. 2024 01 08; 22(5). PMID: 38190801.
      Citations:    Fields:    Translation:Humans
    7. Martel J, Hanania HL, Patel AB. Immune checkpoint inhibitor-induced cutaneous toxicities: a review of histopathologic and clinical features. Hum Pathol. 2023 Oct; 140:144-172. PMID: 37141978.
      Citations:    Fields:    
    8. Muhaj F, Karri PV, Moody W, Brown A, Patel AB. Mucocutaneous adverse events to immune checkpoint inhibitors. Front Allergy. 2023; 4:1147513. PMID: 36938327; PMCID: PMC10017442.
      Citations: 1     
    9. Patel AB, Osterberg EC, Satarasinghe PN, Wenzel JL, Akbani ST, Sahi SL, Emigh BJ, Wolf JS, Brown CVR. Urethral Injuries: Diagnostic and Management Strategies for Critical Care and Trauma Clinicians. J Clin Med. 2023 Feb 13; 12(4). PMID: 36836030; PMCID: PMC9959137.
      Citations:    
    10. Thomas PS, Patel AB, Lee JJ, Liu DD, Hernandez M, Muzzio M, Contreras A, Sepeda V, Mays C, Weber D, Vornik LA, Khan SA, Dimond E, Heckman-Stoddard BM, Perloff M, Brown PH. Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer. Cancer Prev Res (Phila). 2023 01 04; 16(1):47-55. PMID: 36228112; PMCID: PMC10391360.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    11. Brown AM, Masterson W, Lo J, Patel AB. Systemic Treatment of Cutaneous Adverse Events After Immune Checkpoint Inhibitor Therapy: A Review. Dermatitis. 2023 May-Jun; 34(3):201-208. PMID: 34405836.
      Citations:    Fields:    
    12. Dao EA, George SJ, Heberton MM, Pacha O, Kovitz CA, Patel AB, Phillips RM. Erratum to "Periorbital edema associated with alpelisib" [Cancer Treatment and Research Communications 32 (2022) 100596]. Cancer Treat Res Commun. 2022; 33:100654. PMID: 36463021.
      Citations:    Fields:    
    13. Bur D, Patel AB, Nelson K, Huen A, Pacha O, Phillips R, Heberton M. A retrospective case series of 20 patients with immunotherapy-induced bullous pemphigoid with emphasis on management outcomes. J Am Acad Dermatol. 2022 12; 87(6):1394-1395. PMID: 35940366.
      Citations:    
    14. Ravi V, Subramaniam A, Zheng J, Amini B, Trinh VA, Joseph J, Mennel RG, Bishop AJ, Sturgis EM, Goepfert RP, Yalamanchili S, Botello G, Stephen B, Piha-Paul SA, Patel AB, Lazar AJ, Conley AP, Benjamin RS, Patel SR, Futreal PA, Somaiah N, Naing A. Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. Cancer. 2022 09 15; 128(18):3383-3391. PMID: 35792683.
      Citations:    Fields:    
    15. Dao EA, George SJ, Heberton MM, Pacha O, Kovitz CA, Patel AB, Phillips RM. Periorbital edema associated with alpelisib. Cancer Treat Res Commun. 2022; 32:100596. PMID: 35834907.
      Citations:    Fields:    
    16. Patel AB, Satarasinghe PN, Valencia V, Wenzel JL, Webb JC, Wolf JS, Osterberg EC. Opiate Prescriptions Vary among Common Urologic Procedures: A Claims Dataset Analysis. J Clin Med. 2022 Feb 28; 11(5). PMID: 35268419; PMCID: PMC8911322.
      Citations:    
    17. Masterson WM, Brown AM, Al Ameri MA, Patel AB. A retrospective chart review of management strategies for lichenoid eruptions associated with immune-checkpoint inhibitor therapy from a single institution. Cancer Treat Res Commun. 2022; 30:100506. PMID: 34990901.
      Citations:    Fields:    
    18. Patel AB, Farooq S, Welborn M, Amaria RN, Chon SY, Diab A, Glitza Oliva IC, Huen AO, Li SQ, Nelson KC, Pacha O, Patel SP, Rapini RP, Tawbi HA, Wong MK, McQuade J, Davies MA, Haydu LE. Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit. Cancer. 2022 03 01; 128(5):975-983. PMID: 34724197.
      Citations: 1     Fields:    Translation:Humans
    19. Elamin YY, Robichaux JP, Carter BW, Altan M, Gibbons DL, Fossella FV, Lam VK, Patel AB, Negrao MV, Le X, Mott FE, Zhang J, Feng L, Blumenschein G, Tsao AS, Heymach JV. Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial. J Clin Oncol. 2022 03 01; 40(7):702-709. PMID: 34550757; PMCID: PMC8887948.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    20. Lo JJ, Heberton MM, Pacha O, Huen AO, Patel AB. Biologic therapies for checkpoint inhibitor-induced cutaneous toxicities: a single-institution study of 17 consecutively treated patients. Support Care Cancer. 2022 Feb; 30(2):989-994. PMID: 34519869.
      Citations:    Fields:    Translation:Humans
    21. Karri PV, Tahseen D, Gupta R, Grant-Kels JM, Narala S, Patel AB. Can quality keep up with quantity-Longitudinal trends in research output for the dermatology residency match. Clin Dermatol. 2021 Nov-Dec; 39(6):1039-1045. PMID: 34920822.
      Citations: 1     Fields:    Translation:Humans
    22. Hanania HL, Pacha O, Heberton M, Patel AB. Surgical Intervention for Paronychia Induced by Targeted Anticancer Therapies. Dermatol Surg. 2021 06 01; 47(6):775-779. PMID: 34029250.
      Citations:    Fields:    Translation:Humans
    23. Altan M, Patel AB. Management of Cutaneous Immunotherapy Toxicities. Clin Lung Cancer. 2021 09; 22(5):e783. PMID: 33795210.
      Citations:    Fields:    Translation:Humans
    24. Patel AB, Pacha O. Skin Reactions to Immune Checkpoint Inhibitors. Adv Exp Med Biol. 2021; 1342:319-330. PMID: 34972971.
      Citations:    Fields:    Translation:Humans
    25. Narala S, Li SQ, Klimas NK, Patel AB. Application of least absolute shrinkage and selection operator logistic regression for the histopathological comparison of chondrodermatitis nodularis helicis and hyperplastic actinic keratosis. J Cutan Pathol. 2021 Jun; 48(6):739-744. PMID: 33617003.
      Citations: 1     Fields:    Translation:Humans
    26. Karri PV, Freemyer BD, Pacha O, Patel AB. Characterization of Cutaneous Adverse Events Associated With PI3K Inhibitors in 11 Patients. J Immunother Precis Oncol. 2020 Nov; 3(4):141-146. PMID: 35665373; PMCID: PMC9165441.
      Citations:    
    27. Messer A, Drozd B, Glitza IC, Lu H, Patel AB. Dermatomyositis associated with nivolumab therapy for melanoma: a case report and review of the literature. Dermatol Online J. 2020 Aug 15; 26(8). PMID: 32941716.
      Citations: 2     Fields:    Translation:Humans
    28. Welborn M, Kubicki SL, Garg N, Patel AB. Twelve cases of acneiform eruptions while on anti-CTLA4 therapy. Support Care Cancer. 2020 Jun; 28(6):2499-2502. PMID: 32147760.
      Citations: 1     Fields:    Translation:Humans
    29. Patel AB, Pacha O. Skin Reactions to Immune Checkpoint Inhibitors. Adv Exp Med Biol. 2020; 1244:235-246. PMID: 32301018.
      Citations:    Fields:    Translation:Humans
    30. Freemyer BD, Cabala TA, Patel AB. A Case Report of a Cutaneous Mucinous Reaction Associated with Erlotinib Therapy Used in the Treatment of Metastatic Tonsillar Sinus Squamous Cell Carcinoma. J Immunother Precis Oncol. 2020 Feb; 3(1):31-33. PMID: 35756178; PMCID: PMC9208389.
      Citations:    
    31. Wenzel JL, Dixon AN, Patel AB, Webb JC, Satarasinghe PN, Ali S, Brown CVR, Wolf JS, Osterberg EC. Occupational traumatic injuries rarely affect genitourinary organs: a retrospective, comparative study. World J Urol. 2020 Feb; 38(2):505-510. PMID: 31065794; PMCID: PMC7222859.
      Citations:    Fields:    Translation:Humans
    32. Doan HQ, Hu MI, Goldstein J, Piha-Paul SA, Subbiah V, Patel AB. Vandetanib photoinduced cutaneous toxicities. Cutis. 2019 May; 103(5):E24-E29. PMID: 31233590.
      Citations: 1     Fields:    Translation:Humans
    33. Johnson D, Patel AB, Uemura MI, Trinh VA, Jackson N, Zobniw CM, Tetzlaff MT, Hwu P, Curry JL, Diab A. IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy. Cancer Immunol Res. 2019 06; 7(6):860-865. PMID: 30996018.
      Citations: 23     Fields:    Translation:Humans
    34. Rios A, Cen P, Dinh B, Mays SR, Patel AB. Dramatic response of nivolumab-associated psoriasiform dermatitis to etoposide. Eur J Cancer. 2019 01; 107:97-99. PMID: 30554075.
      Citations: 3     Fields:    Translation:Humans
    35. Welborn M, Kubicki SL, Garg N, Patel AB. Retrospective Chart Review of Cutaneous Adverse Events Associated with Tremelimumab in 17 Patients. Am J Clin Dermatol. 2018 Dec; 19(6):899-905. PMID: 30073495.
      Citations: 2     Fields:    Translation:Humans
    36. Chen L, Parsons AM, Aria AB, Ciurea AM, Patel AB, Chan C, Griffin JR, Nguyen TH, Migden MR. Surgical site identification with personal digital device: A prospective pilot study. J Am Acad Dermatol. 2018 Sep; 79(3):520-524. PMID: 29524583.
      Citations:    Fields:    Translation:Humans
    37. Patel AB, Pacha O. Skin Reactions to Immune Checkpoint Inhibitors. Adv Exp Med Biol. 2018; 995:117-129. PMID: 30539508.
      Citations: 3     Fields:    Translation:Humans
    38. Chockalingam R, Aneja S, Patel AB. Primary cutaneous follicle center lymphoma mimicking folliculitis. Cutis. 2018 Jan; 101(1):E30-E33. PMID: 29529119.
      Citations: 1     Fields:    Translation:Humans
    39. Sundaresan S, Nguyen KT, Nelson KC, Ivan D, Patel AB. Erythema multiforme major in a patient with metastatic melanoma treated with nivolumab. Dermatol Online J. 2017 Sep 15; 23(9). PMID: 29469720.
      Citations: 1     Fields:    Translation:Humans
    40. Li JY, Ivan D, Patel AB. Acral retiform purpura. Lancet. 2017 Nov 25; 390(10110):2382. PMID: 28890159.
      Citations:    Fields:    Translation:Humans
    41. Patel AB, Pacha O. Skin Reactions to Immune Checkpoint Inhibitors. Adv Exp Med Biol. 2017; 995:175-184. PMID: 28321818.
      Citations: 2     Fields:    Translation:HumansCells
    42. Patel AB, Solomon AR, Mauro MJ, Ehst BD. Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia. Dermatology. 2016; 232(1):122-5. PMID: 26352467.
      Citations: 10     Fields:    Translation:Humans
    43. Goldstein J, Patel AB, Curry JL, Subbiah V, Piha-Paul S. Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma: a case report. BMC Dermatol. 2015 Feb 13; 15:2. PMID: 25886034; PMCID: PMC4336708.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    44. Patel T, Patel AB, Moody M, Kelly B, Gibson B. Tzanck smear for quick screening of transient myeloproliferative disorder in neonates with vesiculopapular eruptions. Int J Dermatol. 2015 Jul; 54(7):e251-3. PMID: 24738623.
      Citations:    Fields:    Translation:Humans
    45. Patel AB, Hill E, Simpson EL, Hanifin JM. Reversion of methicillin-resistant Staphylococcus aureus skin infections to methicillin-susceptible isolates. JAMA Dermatol. 2013 Oct; 149(10):1167-71. PMID: 23945667.
      Citations: 3     Fields:    Translation:HumansCells
    46. Patel AB, Kubba R, Kubba A. Clinicopathological correlation of acquired hyperpigmentary disorders. Indian J Dermatol Venereol Leprol. 2013 May-Jun; 79(3):367-75. PMID: 23619441.
      Citations: 6     Fields:    Translation:Humans
    47. Patel AB, Kubba R, Kubba A. Clinicopathological correlation of acquired hypopigmentary disorders. Indian J Dermatol Venereol Leprol. 2013 May-Jun; 79(3):376-82. PMID: 23619442.
      Citations: 4     Fields:    Translation:Humans
    48. Patel AB, Rosen T. Herpes vegetans as a sign of HIV infection. Dermatol Online J. 2008 Apr 15; 14(4):6. PMID: 18627728.
      Citations: 4     Fields:    Translation:HumansCells
    49. Patel AB, Harting MS, Smith-Zagone MJ, Hsu S. Familial basaloid follicular hamartoma: a report of one family. Dermatol Online J. 2008 Apr 15; 14(4):14. PMID: 18627736.
      Citations: 4     Fields:    Translation:Humans
    50. Patel AB, Katta R. Neomycin. Dermatitis. 2008 Mar-Apr; 19(2):E7-8. PMID: 18413103.
      Citations:    Fields:    Translation:Humans
    51. Regorafenib- Associated panniculitis. Dermatology Online Journal. 22.
    52. Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia. Dermatology. 232:122-125.
    53. Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma. Journal of Cutaneous Pathology.
    54. Photoallergic reaction in a patient receiving vandetanib for metastatic follicular thyroid carcinoma. BMC Dermatology. 1-5.
    55. Contact allergens relevant to dermatitis in special locations. Journal of Drugs in Dermatology. 11:657-658.
    PATEL's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (167)
    Explore
    _
    Co-Authors (48)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _